Fas (Fas cell surface death receptor) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Fas (Fas cell surface death receptor) Rattus norvegicus
Symbol: Fas
Name: Fas cell surface death receptor
RGD ID: 619831
Description: Enables protease binding activity and tumor necrosis factor-activated receptor activity. Involved in several processes, including cellular response to cytokine stimulus; cellular response to estrogen stimulus; and nervous system development. Located in several cellular components, including apical dendrite; apical plasma membrane; and sarcolemma. Part of CD95 death-inducing signaling complex. Used to study IgA glomerulonephritis; brain glioma; pre-malignant neoplasm; retinal detachment; and transient cerebral ischemia. Biomarker of several diseases, including abdominal obesity-metabolic syndrome 1; artery disease (multiple); brain ischemia (multiple); eye disease (multiple); and liver disease (multiple). Human ortholog(s) of this gene implicated in several diseases, including autoimmune disease (multiple); cystic fibrosis; hematologic cancer (multiple); pre-eclampsia (multiple); and urinary system cancer (multiple). Orthologous to human FAS (Fas cell surface death receptor); PARTICIPATES IN extrinsic apoptotic pathway; FasL mediated signaling pathway; intrinsic apoptotic pathway; INTERACTS WITH (S)-nicotine; 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; 1,2-dimethylhydrazine.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: apo-1 antigen; apoptosis-mediating surface antigen FAS; CD95 antigen; Fas (TNF receptor superfamily, member 6); Fas antigen (ATP1); Fas receptor; FASLG receptor; Tnfrsf6; tumor necrosis factor receptor superfamily member 6; Tumor necrosis factor receptor superfamily, member 6
RGD Orthologs
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.21231,798,963 - 231,832,591 (+)NCBImRatBN7.2
mRatBN7.2 Ensembl1231,798,960 - 231,832,591 (+)Ensembl
Rnor_6.01252,589,785 - 252,624,790 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1252,589,785 - 252,624,790 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01259,812,248 - 259,846,107 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41238,259,443 - 238,274,745 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11238,423,465 - 238,438,767 (+)NCBI
Celera1228,912,823 - 228,946,152 (+)NCBICelera
Cytogenetic Map1q52NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations     Click to see Annotation Detail View
abdominal obesity-metabolic syndrome 1  (IEP)
Acute Experimental Pancreatitis  (ISO)
acute kidney failure  (ISO)
Acute Liver Failure  (ISO)
Acute Lung Injury  (ISO)
acute lymphoblastic leukemia  (ISO)
acute myeloid leukemia  (ISO)
adult T-cell leukemia  (ISO)
alcoholic hepatitis  (IEP)
Alcoholic Liver Diseases  (ISO)
Alzheimer's disease  (ISO)
Animal Disease Models  (ISO)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis  (ISO)
aplastic anemia  (ISO)
asthma  (IEP)
atherosclerosis  (IEP)
autoimmune disease  (ISO)
autoimmune hepatitis  (ISO)
autoimmune lymphoproliferative syndrome  (ISO)
Autoimmune Lymphoproliferative Syndrome, Type IA  (ISO)
autoimmune thrombocytopenic purpura  (ISO)
B-Cell Chronic Lymphocytic Leukemia  (ISO)
Barrett's esophagus  (ISO)
Behcet's disease  (ISO)
brain glioma  (IDA)
Brain Injuries  (IEP,ISO)
brain ischemia  (IEP)
breast cancer  (ISO)
breast carcinoma  (ISO)
cardiomyopathy  (ISO)
Cardiovascular Pregnancy Complications  (ISO)
cataract  (ISO)
Chemical and Drug Induced Liver Injury  (IEP)
Chest Trauma  (IEP)
chorioamnionitis  (ISO)
chronic conjunctivitis  (ISO)
chronic myeloid leukemia  (ISO)
chronic obstructive pulmonary disease  (IEP)
Chronic Uveitis  (ISO)
clonorchiasis  (IEP)
Colonic Neoplasms  (IEP)
congestive heart failure  (IEP,ISO)
corneal neovascularization  (ISO)
cryptorchidism  (IEP)
cutaneous T cell lymphoma  (ISO)
cystic fibrosis  (ISO)
dermatomyositis  (ISO)
diabetic angiopathy  (ISO)
Diabetic Nephropathies  (IEP,ISO)
diffuse large B-cell lymphoma  (ISO)
dilated cardiomyopathy  (IEP,ISO)
Disease Progression  (ISO)
endophthalmitis  (IEP)
Endotoxemia  (IEP)
Esophageal Neoplasms  (ISO)
esophagus adenocarcinoma  (ISO)
Experimental Allergic Asthma  (IEP)
Experimental Autoimmune Uveitis  (ISO)
Experimental Colitis  (IDA)
Experimental Diabetes Mellitus  (IEP,ISO)
Experimental Liver Cirrhosis  (IEP,ISO)
Experimental Liver Neoplasms  (ISO)
Fetal Growth Retardation  (ISO)
gastric ulcer  (IEP)
genetic disease  (ISO)
glaucoma  (ISO)
glomerulonephritis  (ISO)
Graft vs Host Disease  (ISO)
Graves' disease  (ISO)
Hashimoto Disease  (ISO)
HELLP syndrome  (IEP,ISO)
hematopoietic system disease  (ISO)
hepatitis B  (ISO)
hepatoblastoma  (ISO)
hepatocellular carcinoma  (IEP,ISO)
heroin dependence  (IEP)
high grade glioma  (ISO)
human immunodeficiency virus infectious disease  (ISO)
Huntington's disease  (ISO)
Hyperoxia  (IEP,ISO)
hypersplenism  (ISO)
Hypothermia  (IEP)
Hypoxia-Ischemia, Brain  (IEP)
idiopathic pulmonary fibrosis  (ISO)
IgA glomerulonephritis  (IDA)
inclusion body myositis  (ISO)
infectious mononucleosis  (ISO)
Insulin Resistance  (IEP)
intrahepatic cholangiocarcinoma  (ISO)
Kashin-Beck Disease  (ISO)
Kidney Reperfusion Injury  (IEP)
limited scleroderma  (ISO)
liver disease  (IEP)
Liver Injury  (ISO)
Liver Reperfusion Injury  (IEP,IMP)
Lung Neoplasms  (ISO)
lupus nephritis  (ISO)
Lymphatic Metastasis  (ISO)
Lymphomatoid Papulosis  (ISO)
lymphoproliferative syndrome  (ISO)
macular degeneration  (ISO)
male infertility  (IEP)
Mammary Neoplasms, Experimental  (ISO)
melanoma  (ISO)
Metabolic Brain Diseases  (IEP)
mixed connective tissue disease  (ISO)
Moyamoya disease  (ISO)
multiple sclerosis  (ISO)
multiple system atrophy  (ISO)
Multisystemic Smooth Muscle Dysfunction Syndrome  (ISO)
myasthenia gravis  (ISO)
myelodysplastic syndrome  (ISO)
Myocardial Reperfusion Injury  (IDA)
Nasal Polyps  (ISO)
nasal type extranodal NK/T-cell lymphoma  (ISO)
Necrosis  (ISO)
Neoplasm Metastasis  (ISO)
nephritis  (ISO)
non-alcoholic fatty liver disease  (ISO)
ocular hypertension  (IEP)
ovarian cancer  (ISO)
Oxygen-Induced Retinopathy  (ISO)
Parkinson's disease  (ISO)
peripheral vascular disease  (ISO)
Plasmodium falciparum malaria  (ISO)
pre-eclampsia  (ISO)
pre-malignant neoplasm  (IDA)
primary biliary cholangitis  (ISO)
primary immunodeficiency disease  (ISO)
prostate cancer  (ISO)
Prostatic Neoplasms  (ISO)
proteinuria  (ISO)
Puromycin Aminonucleoside Nephrosis  (IEP)
Radiation Injuries, Experimental  (IEP)
relapsing-remitting multiple sclerosis  (ISO)
renal cell carcinoma  (ISO)
Reperfusion Injury  (IDA)
retinal detachment  (IEP,IMP)
retinoblastoma  (ISO)
rheumatoid arthritis  (ISO)
sciatic neuropathy  (IEP)
seminoma  (ISO)
Sepsis  (IEP)
Sjogren's syndrome  (ISO,ISS)
Spinal Cord Compression  (ISO)
Spinal Cord Injuries  (IDA,IEP)
Splenomegaly  (ISO)
squamous cell carcinoma  (ISO)
systemic lupus erythematosus  (ISO,ISS)
Taste Disorders  (ISO)
Temporomandibular Joint Osteoarthritis  (IEP)
Testicular Injury  (ISO)
thoracic aortic aneurysm  (ISO)
transient cerebral ischemia  (IDA,IEP,ISO)
transitional cell carcinoma  (ISO)
type 1 diabetes mellitus  (ISO)
type 2 diabetes mellitus  (ISO)
ulcerative colitis  (IEP)
urinary bladder cancer  (ISO)
varicocele  (IEP)
Ventricular Dysfunction, Left  (ISO)
Viral Bronchiolitis  (ISO)
visual epilepsy  (IEP)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-catechin  (ISO)
(-)-anisomycin  (ISO)
(-)-demecolcine  (ISO)
(R)-adrenaline  (ISO)
(R)-lipoic acid  (ISO)
(S)-colchicine  (ISO)
(S)-nicotine  (EXP,ISO)
(Z)-3-butylidenephthalide  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (EXP,ISO)
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose  (ISO)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (EXP,ISO)
1-naphthyl isothiocyanate  (EXP)
1-nitropropane  (EXP)
15-deoxy-Delta(12,14)-prostaglandin J2  (ISO)
17alpha-ethynylestradiol  (EXP)
17beta-estradiol  (ISO)
17beta-estradiol 3-benzoate  (EXP)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4-diaminotoluene  (EXP)
2,4-dinitrotoluene  (EXP)
2,6-diaminotoluene  (EXP)
2,6-dinitrotoluene  (EXP)
2-acetamidofluorene  (EXP)
2-amino-2-deoxy-D-glucopyranose 6-phosphate  (ISO)
2-bromohexadecanoic acid  (ISO)
2-nitro-p-phenylenediamine  (EXP)
2-nitropropane  (EXP)
2-nitrotoluene  (EXP)
25-hydroxycholesterol  (ISO)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (EXP)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5,5'-tetrabromobisphenol A  (EXP)
3,4-methylenedioxymethamphetamine  (ISO)
3-chloropropane-1,2-diol  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
3-methylcholanthrene  (ISO)
3-phenylprop-2-enal  (ISO)
4'-epidoxorubicin  (EXP)
4,4'-diaminodiphenylmethane  (ISO)
4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid  (ISO)
4-acetylaminofluorene  (EXP)
4-nitro-1,2-phenylenediamine  (EXP)
4-nitro-m-cresol  (ISO)
4-nitrophenol  (ISO)
4-nonylphenol  (EXP)
4-tert-butylphenol  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-fluorouracil  (ISO)
7,12-dimethyltetraphene  (ISO)
8'-apo-beta,psi-caroten-8'-al  (ISO)
9-cis-retinoic acid  (ISO)
[6]-Shogaol  (ISO)
acetamide  (EXP)
acetylsalicylic acid  (EXP,ISO)
acrolein  (ISO)
acrylamide  (EXP)
Actein  (EXP)
adefovir pivoxil  (ISO)
aflatoxin B1  (EXP,ISO)
aldehydo-D-glucosamine 6-phosphate  (ISO)
aldehydo-D-glucose  (ISO)
all-trans-4-oxoretinoic acid  (ISO)
all-trans-4-oxoretinol  (ISO)
all-trans-acitretin  (ISO)
all-trans-retinoic acid  (ISO)
all-trans-retinol  (ISO)
Aloe emodin  (ISO)
Aloperine  (EXP)
alpha-naphthoflavone  (ISO)
alpha-pinene  (ISO)
alpinumisoflavone  (ISO)
ammonium chloride  (EXP)
andrographolide  (ISO)
anthocyanin  (EXP)
anthra[1,9-cd]pyrazol-6(2H)-one  (ISO)
anthracen-2-amine  (EXP)
antimycin A  (ISO)
apigenin  (EXP,ISO)
apocynin  (EXP)
arachidonic acid  (ISO)
arecoline  (EXP)
arjunolic acid  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenous acid  (ISO)
artesunate  (ISO)
asbestos  (ISO)
atenolol  (ISO)
atorvastatin calcium  (EXP)
Aurothioglucose  (ISO)
benazepril  (EXP)
bentonite  (EXP)
benzene-1,2,4-triol  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (ISO)
berberine  (ISO)
beta-carotene  (ISO)
beta-D-glucosamine 6-sulfate  (ISO)
bezafibrate  (EXP,ISO)
bis(2-chloroethyl) sulfide  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
bortezomib  (ISO)
bromochloroacetic acid  (EXP)
bucladesine  (EXP)
bufalin  (ISO)
buta-1,3-diene  (ISO)
butyric acid  (ISO)
Cacalol  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (EXP)
Calcimycin  (ISO)
calcitriol  (ISO)
camptothecin  (ISO)
cannabidiol  (ISO)
capsaicin  (EXP,ISO)
carbamazepine  (ISO)
carbon nanotube  (ISO)
carboplatin  (ISO)
carnosic acid  (ISO)
carvedilol  (ISO)
casticin  (ISO)
catechol  (ISO)
celastrol  (ISO)
celecoxib  (ISO)
cetrorelix  (EXP,ISO)
charcoal  (EXP)
chlorambucil  (ISO)
chloroacetaldehyde  (ISO)
chloroprene  (ISO)
chlorpromazine  (ISO)
chlorpyrifos  (ISO)
cholesterol  (EXP,ISO)
choline  (ISO)
chromium(6+)  (ISO)
chrysazin  (ISO)
cidofovir anhydrous  (ISO)
Cinobufotalin  (ISO)
cisplatin  (EXP,ISO)
clobetasol  (ISO)
clodronic acid  (ISO)
clofazimine  (EXP)
clofibrate  (ISO)
clorgyline  (ISO)
clotrimazole  (ISO)
clozapine  (ISO)
cobalt atom  (ISO)
cobalt dichloride  (ISO)
cocaine  (ISO)
copanlisib  (ISO)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
copper(II) sulfate  (ISO)
corosolic acid  (ISO)
cortisol  (ISO)
crocidolite asbestos  (EXP,ISO)
Cuprizon  (EXP)
curcumin  (ISO)
cycloheximide  (ISO)
cyclophosphamide  (EXP,ISO)
cyclosporin A  (ISO)
cylindrospermopsin  (ISO)
cypermethrin  (ISO)
cyproconazole  (EXP)
cytarabine  (EXP,ISO)
D-glucose  (ISO)
daunorubicin  (ISO)
deguelin  (ISO)
deoxynivalenol  (EXP)
dexamethasone  (EXP,ISO)
Diallyl sulfide  (ISO)
diallyl trisulfide  (ISO)
diamminedichloroplatinum  (ISO)
diarsenic trioxide  (ISO)
diazinon  (EXP,ISO)
dibenzo[a,l]pyrene  (ISO)
dibromoacetic acid  (ISO)
dichlorine  (EXP)
dichlorvos  (ISO)
diclofenac  (ISO)
diethylstilbestrol  (EXP,ISO)
dihydroartemisinin  (EXP)
dimethyl sulfoxide  (ISO)
dimethylarsinic acid  (ISO)
dioscin  (ISO)
diosgenin  (ISO)
dioxygen  (ISO)
diuron  (EXP)
dorsomorphin  (ISO)
doxorubicin  (EXP,ISO)
EC (peptidyl-dipeptidase A) inhibitor  (ISO)
Echimidine  (ISO)
elemental selenium  (ISO)
emodin  (EXP,ISO)
endosulfan  (EXP)
enilconazole  (ISO)
entinostat  (ISO)
epoxiconazole  (EXP)
esculetin  (ISO)
ethanol  (EXP,ISO)
ethyl methanesulfonate  (ISO)
etoposide  (ISO)
fenofibrate  (EXP,ISO)
ferrosoferric oxide  (ISO)
fingolimod hydrochloride  (ISO)
flavanone  (ISO)
flavonoids  (ISO)
folic acid  (ISO)
formaldehyde  (EXP,ISO)
fotemustine  (ISO)
fructose  (ISO)
fumonisin B1  (ISO)
furan  (EXP)
Fusarenone X  (ISO)
gamma-hexachlorocyclohexane  (EXP)
gemcitabine  (ISO)
genistein  (EXP,ISO)
gentamycin  (EXP)
gibberellin A3  (EXP)
gingerol  (ISO)
ginsenoside Re  (ISO)
glucose  (ISO)
glutathione  (ISO)
glutathione disulfide  (ISO)
glyphosate  (ISO)
gold atom  (ISO)
gold(0)  (ISO)
gossypol  (EXP)
GSK690693  (ISO)
guggulsterone  (EXP)
GW 4064  (EXP)
Heliotrine  (EXP,ISO)
heparin  (ISO)
heroin  (ISO)
hexachlorobenzene  (EXP)
hexadecanoic acid  (EXP,ISO)
Honokiol  (EXP)
hydrogen peroxide  (EXP,ISO)
hydrogen sulfide  (ISO)
hydroquinone  (ISO)
hydroxychloroquine  (ISO)
hydroxyurea  (ISO)
hyperforin  (ISO)
ibuprofen  (ISO)
ICI D1694  (ISO)
idelalisib  (ISO)
inulin  (ISO)
irinotecan  (ISO)
isoflavones  (EXP)
isoprenaline  (EXP,ISO)
ivermectin  (ISO)
ketoconazole  (EXP,ISO)
L-methionine  (ISO)
lansoprazole  (EXP)
Lasiocarpine  (ISO)
lead diacetate  (ISO)
lead(0)  (ISO)
lead(2+)  (ISO)
leukotriene D4  (ISO)
Licochalcone A  (ISO)
lipoic acid  (ISO)
lipopolysaccharide  (EXP,ISO)
lithium atom  (ISO)
lithium hydride  (ISO)
lithocholic acid  (ISO)
lovastatin  (ISO)
luteolin  (EXP)
LY294002  (ISO)
magnesium oxide  (ISO)
mancozeb  (ISO)
maneb  (ISO)
manganese(II) chloride  (EXP)
mangiferin  (ISO)
masoprocol  (ISO)
medroxyprogesterone acetate  (ISO)
melatonin  (EXP,ISO)
melittin  (ISO)
menadione  (ISO)
mercury atom  (ISO)
mercury dibromide  (ISO)
mercury dichloride  (ISO)
mercury(0)  (ISO)
metformin  (EXP)
methamphetamine  (EXP)
methotrexate  (ISO)
methoxychlor  (EXP)
methyl methanesulfonate  (ISO)
methylarsonic acid  (ISO)
methylmercury chloride  (ISO)
methyltestosterone  (EXP)
mifepristone  (ISO)
miquelianin  (EXP)
mitogen  (ISO)
mitomycin C  (ISO)
mitoxantrone  (ISO)
MK-2206  (ISO)
montelukast  (ISO)
morin  (EXP)
morphine  (ISO)
myriocin  (ISO)
Myrtucommulone A  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (EXP)
N-acetyl-L-cysteine  (EXP,ISO)
N-methyl-4-phenylpyridinium  (EXP)
N-nitrosodiethylamine  (EXP,ISO)
N-Nitrosopyrrolidine  (ISO)
naproxen  (EXP)
naringin  (ISO)
nickel atom  (ISO)
nickel dichloride  (EXP)
niclosamide  (EXP,ISO)
nicotine  (EXP,ISO)
nitric oxide  (ISO)
nitrobenzene  (ISO)
nitroglycerin  (ISO)
Nodularin  (ISO)
notoginsenoside R1  (ISO)
Nutlin-3  (ISO)
nystatin  (ISO)
obeticholic acid  (EXP)
ochratoxin A  (EXP,ISO)
octreotide  (ISO)
okadaic acid  (ISO)
oleic acid  (EXP,ISO)
olmesartan  (ISO)
orlistat  (ISO)
osthole  (ISO)
ouabain  (ISO)
ozone  (EXP,ISO)
p-menthan-3-ol  (ISO)
paclitaxel  (ISO)
Panduratin A  (ISO)
paracetamol  (EXP,ISO)
paraquat  (ISO)
parthenolide  (ISO)
pemetrexed  (ISO)
Pentoxifylline  (ISO)
perfluorodecanoic acid  (ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorononanoic acid  (EXP)
perfluorooctane-1-sulfonic acid  (ISO)
perfluoroundecanoic acid  (ISO)
perifosine  (ISO)
permethrin  (ISO)
phenethyl caffeate  (ISO)
phenobarbital  (ISO)
phenol  (ISO)
phenylmercury acetate  (ISO)
phlorizin  (ISO)
phorbol 13-acetate 12-myristate  (ISO)
picoxystrobin  (ISO)
pirinixic acid  (ISO)
platycodin D  (ISO)
plumbagin  (ISO)
potassium bromate  (ISO)
pregnenolone 16alpha-carbonitrile  (EXP)
prochloraz  (EXP)
procyanidin B3  (ISO)
propanal  (ISO)
propiconazole  (ISO)
propofol  (ISO)
propranolol  (EXP)
prostaglandin E2  (ISO)
pterostilbene  (ISO)
quercetin  (EXP,ISO)
quercitrin  (ISO)
reactive oxygen species  (ISO)
regorafenib  (ISO)
resveratrol  (EXP,ISO)
ribavirin  (ISO)
riddelliine  (EXP)
rifampicin  (ISO)
risperidone  (ISO)
Roridin A  (ISO)
rotenone  (ISO)
S-allylcysteine  (ISO)
S-butyl-DL-homocysteine (S,R)-sulfoximine  (EXP)
sanguinarine  (ISO)
SB 203580  (ISO)
SB 415286  (ISO)
SB 431542  (ISO)
selenium atom  (ISO)
senecionine  (EXP,ISO)
Senkirkine  (ISO)
silicon dioxide  (EXP,ISO)
sirolimus  (ISO)
sodium arsenite  (ISO)
sodium dichromate  (EXP)
sodium fluoride  (ISO)
Soman  (EXP)
sorafenib  (ISO)
streptozocin  (EXP)
succimer  (ISO)
sucrose  (EXP)
sulforaphane  (ISO)
sumatriptan  (EXP)
tacrolimus hydrate  (ISO)
tamibarotene  (ISO)
taurine  (ISO)
tauroursodeoxycholic acid  (EXP)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP)
tetrachloromethane  (EXP,ISO)
tetracycline  (ISO)
tetrazolium violet  (ISO)
thalidomide  (EXP,ISO)
thapsigargin  (ISO)
thiazoles  (ISO)
thimerosal  (ISO)
thioacetamide  (EXP)
thiosalicylic acid  (EXP)
thymol  (EXP)
thymol sulfate(1-)  (EXP)
titanium dioxide  (EXP,ISO)
toluene  (EXP)
topotecan  (ISO)
transplatin  (ISO)
tributylstannane  (EXP)
Tributyltin oxide  (ISO)
trichloroethene  (EXP)
trichostatin A  (ISO)
trimethyltin  (ISO)
triphenyl phosphate  (EXP)
Triptolide  (ISO)
troglitazone  (EXP,ISO)
tubocurarine  (ISO)
Tungsten carbide  (ISO)
tunicamycin  (ISO)
urethane  (ISO)
valproic acid  (ISO)
valsartan  (EXP)
vanillic acid  (EXP)
vinclozolin  (EXP)
vincristine  (ISO)
vinorelbine  (ISO)
vismodegib  (ISO)
vorinostat  (ISO)
wortmannin  (ISO)
Y-27632  (ISO)
zearalenone  (EXP)
zidovudine  (ISO)
zinc atom  (ISO)
zinc oxide  (ISO)
zinc(0)  (ISO)
zoledronic acid  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
activation-induced cell death of T cells  (IBA,ISO)
aging  (IEP)
apoptotic process  (IEA,ISO,TAS)
apoptotic signaling pathway  (IMP,ISO)
B cell mediated immunity  (ISO)
cellular response to amino acid starvation  (ISO)
cellular response to cobalt ion  (IEP)
cellular response to cytokine stimulus  (IEP)
cellular response to estrogen stimulus  (IEP)
cellular response to glucose stimulus  (IEP)
cellular response to hydrogen peroxide  (IEP)
cellular response to hydrostatic pressure  (IEP)
cellular response to hyperoxia  (ISO)
cellular response to hypoxia  (IEP)
cellular response to interferon-gamma  (IEP)
cellular response to interleukin-1  (IEP)
cellular response to lithium ion  (ISO)
cellular response to mechanical stimulus  (ISO)
cellular response to organic cyclic compound  (IEP)
cellular response to phenylalanine  (IEP)
cellular response to tumor necrosis factor  (IEP)
chordate embryonic development  (IEP)
circadian rhythm  (ISO)
dendrite regeneration  (IMP)
extrinsic apoptotic signaling pathway  (ISO)
extrinsic apoptotic signaling pathway in absence of ligand  (IBA,ISO)
extrinsic apoptotic signaling pathway via death domain receptors  (ISO)
Fas signaling pathway  (ISO)
gene expression  (ISO)
hepatocyte apoptotic process  (ISO)
immune response  (IEA)
inflammatory cell apoptotic process  (ISO)
lipid localization  (IEP)
liver regeneration  (IEP)
lymphocyte apoptotic process  (ISO)
maternal process involved in female pregnancy  (IEP)
motor neuron apoptotic process  (IBA,ISO)
necroptotic signaling pathway  (IBA,ISO)
negative regulation of apoptotic process  (IBA,ISO)
negative regulation of B cell activation  (ISO)
negative regulation of Schwann cell migration  (IMP)
negative regulation of Schwann cell proliferation  (IMP)
negative thymic T cell selection  (ISO)
neuron apoptotic process  (ISO)
ovarian follicle atresia  (IEP)
ovulation cycle  (IEP)
positive regulation of apoptotic process  (IMP,ISO)
positive regulation of apoptotic signaling pathway  (ISO)
positive regulation of cell death  (IMP)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process  (IMP)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway  (IBA,ISO)
positive regulation of neuron apoptotic process  (IMP)
positive regulation of protein phosphorylation  (ISO)
positive regulation of protein-containing complex assembly  (ISO)
regulation of apoptotic process  (IMP)
regulation of cell population proliferation  (IMP)
regulation of gene expression  (IMP)
regulation of lipid storage  (IEP)
regulation of lymphocyte differentiation  (ISO)
regulation of myeloid cell differentiation  (ISO)
regulation of stress-activated MAPK cascade  (IBA,ISO)
response to cycloheximide  (IEP)
response to cytokine  (IEP)
response to estrogen  (IEP)
response to ethanol  (IEP)
response to fluoride  (IEP)
response to glucocorticoid  (ISO)
response to growth factor  (IEP)
response to hypoxia  (IEP)
response to inorganic substance  (IEP)
response to lipopolysaccharide  (IEP)
response to nutrient levels  (IEP)
response to organic cyclic compound  (IEP)
response to peptide hormone  (IEP)
response to toxic substance  (IEP,ISO)
response to xenobiotic stimulus  (IEP)
signal transduction  (IEA)
spermatogenesis  (IEP)
spleen development  (ISO)
T cell homeostasis  (ISO)
telencephalon development  (IEP)
tumor necrosis factor-mediated signaling pathway  (IEA)


References - curated
1. Ackery A, etal., J Neurotrauma. 2006 May;23(5):604-16.
2. Al-Tamimi J, etal., Cancer Biother Radiopharm. 2018 Mar;33(2):65-73. doi: 10.1089/cbr.2017.2400.
3. Amasaki Y, etal., Clin Exp Immunol. 1995 Feb;99(2):245-50.
4. Anthony RS, etal., Leuk Lymphoma. 1998 Aug;30(5-6):449-58.
5. Ares-Carrasco S, etal., Am J Physiol Heart Circ Physiol. 2009 Oct 9.
6. Baldini E, etal., Int J Androl. 2007 Oct 3;.
7. Balkundi DR, etal., Biol Reprod. 2003 Aug;69(2):718-24. Epub 2003 Apr 16.
8. Bamri-Ezzine S, etal., Lab Invest. 2003 Jul;83(7):1069-80.
9. Baryshnikov AYu, etal., Adv Exp Med Biol. 1999;457:251-8.
10. Bebenek M, etal., Anticancer Res. 2007 Jan-Feb;27(1A):215-8.
11. Belkacemi L, etal., Placenta. 2009 Sep;30(9):739-51. doi: 10.1016/j.placenta.2009.06.003. Epub 2009 Jul 18.
12. Bettinardi A, etal., Blood. 1997 Feb 1;89(3):902-9.
13. Brignole F, etal., Exp Eye Res. 1998 Dec;67(6):687-97.
14. Casha S, etal., Exp Neurol. 2005 Dec;196(2):390-400. Epub 2005 Oct 3.
15. Celik-Ozenci C, etal., Fertil Steril. 2006 Apr;85 Suppl 1:1168-78.
16. Ceotto Freitas-Lima L, etal., Toxicol Lett. 2018 Aug 29. pii: S0378-4274(18)31826-5. doi: 10.1016/j.toxlet.2018.08.018.
17. Cheema ZF, etal., BMC Neurosci. 2004 Mar 23;5:11.
18. Cheema ZF, etal., J Neurosci. 1999 Mar 1;19(5):1754-70.
19. Chen Q, etal., Endocrinology 2005 Feb;146(2):808-15. Epub 2004 Nov 4.
20. Choi Y, etal., Clin Immunol. 1999 Oct;93(1):34-45.
21. Christensson M, etal., J Clin Immunol. 2002 Jul;22(4):220-7.
22. Chua CC, etal., Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2606-13.
23. Coppola D, etal., Ann Surg Oncol. 1999 Apr-May;6(3):298-304.
24. Cosson E, etal., Diabetes Metab. 2005 Feb;31(1):47-54.
25. Cubero FJ, etal., Cell Death Dis. 2019 Feb 8;10(2):115. doi: 10.1038/s41419-019-1391-x.
26. Cudrici C, etal., J Immunol. 2006 Mar 1;176(5):3173-80.
27. Dasari VR, etal., Neurochem Res. 2008 Jan;33(1):134-49. Epub 2007 Aug 17.
28. Davis AR, etal., J Neurotrauma. 2007 May;24(5):823-34.
29. de la Taille A, etal., Prostate. 1999 Jul 1;40(2):89-96.
30. Dowling P, etal., J Exp Med. 1996 Oct 1;184(4):1513-8.
31. Dzietko M, etal., Ann Neurol. 2008 Dec;64(6):664-73. doi: 10.1002/ana.21516.
32. Edathara PM, etal., Tumour Biol. 2015 Nov 13.
33. Facchinetti F, etal., J Neurosci Res 2002 Jul 15;69(2):178-88.
34. Farre L, etal., J Leukoc Biol. 2008 Jan;83(1):220-2. Epub 2007 Oct 25.
35. Ferrer I, etal., Neuropathol Appl Neurobiol. 2000 Oct;26(5):424-33.
36. Feuk L, etal., Hum Genet 2000 Oct;107(4):391-6.
37. Fleck M, etal., Arthritis Rheum. 1998 Dec;41(12):2175-84.
38. Frankel B, etal., Neurosurgery. 2001 Jul;49(1):168-75; discussion 175-6.
39. Fujihara T, etal., Clin Rheumatol. 1998;17(6):496-9.
40. Fyhr IM and Oldfors A, Ann Neurol. 1998 Jan;43(1):127-30.
41. Gallagher SF, etal., J Gastrointest Surg. 2005 Apr;9(4):467-74; discussion 474-5. doi: 10.1016/j.gassur.2004.12.008.
42. Gao Y, etal., Int J Cardiol. 2011 Oct 20;152(2):177-83. doi: 10.1016/j.ijcard.2010.07.012. Epub 2011 Feb 12.
43. Garcia-Fuster MJ, etal., Naunyn Schmiedebergs Arch Pharmacol. 2003 Nov;368(5):421-31. Epub 2003 Oct 3.
44. Garcia-Unzueta MT, etal., Horm Metab Res. 2006 Oct;38(10):673-7.
45. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
46. Gibbens J, etal., Pregnancy Hypertens. 2017 Apr;8:26-30. doi: 10.1016/j.preghy.2017.02.004. Epub 2017 Feb 24.
47. Gong ZM, etal., Biochem Biophys Res Commun. 2018 Jun 22;501(2):501-506. doi: 10.1016/j.bbrc.2018.05.022. Epub 2018 May 16.
48. Gratas C, etal., Cancer Res. 1998 May 15;58(10):2057-62.
49. Gravekamp C, etal., Cancer Immunol Immunother. 2007 Dec 20;.
50. Groneberg C, etal., Exp Hematol. 2003 Aug;31(8):682-5.
51. Hakuno N, etal., Endocrinology. 1996 May;137(5):1938-48.
52. Hamzaoui K, etal., Mediators Inflamm. 1998;7(2):111-4.
53. Han D, etal., Acta Biochim Biophys Sin (Shanghai). 2009 Nov;41(11):938-47.
54. Hanafusa T and Imagawa A, Ann N Y Acad Sci. 2008 Dec;1150:297-9.
55. Hao Z, etal., J Exp Med. 2004 May 17;199(10):1355-65.
56. Hendawy N, Biomed Pharmacother. 2017 Aug;92:316-323. doi: 10.1016/j.biopha.2017.05.084. Epub 2017 May 25.
57. Hinton DR, etal., Arch Ophthalmol. 1998 Feb;116(2):203-9.
58. Hirano T, etal., Res Commun Mol Pathol Pharmacol. 2003;113-114:315-28.
59. Hou XW, etal., Cardiovasc Drugs Ther. 2006 Apr;20(2):85-91.
60. Houghton J, etal., Infect Immun. 2000 Mar;68(3):1189-95.
61. Huang X, etal., PLoS One. 2013 Aug 7;8(8):e71553. doi: 10.1371/journal.pone.0071553. Print 2013.
62. Ioachim HL, etal., Pathol Res Pract. 2005;200(11-12):743-51.
63. Itoh N, etal., J Exp Med. 1997 Aug 18;186(4):613-8.
64. Jabs DA, etal., Invest Ophthalmol Vis Sci. 2001 Feb;42(2):399-401.
65. Jaita G, etal., Endocrinology. 2005 Nov;146(11):4737-44. Epub 2005 Aug 11.
66. Jeong JH, etal., J Control Release. 2009 Dec 14.
67. Jiang H, etal., World J Surg. 2005 Nov;29(11):1397-401.
68. Jin H, etal., Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004 Mar;39(3):143-6.
69. Ju KR, etal., Brain Res. 2006 Nov 29;1122(1):209-21. Epub 2006 Oct 11.
70. Jung JY and Kim WJ, Neurosci Lett. 2004 Nov 23;371(2-3):85-90.
71. Kang S, etal., Cancer Genet Cytogenet. 2008 Jan 1;180(1):1-5.
72. Kawamura K, etal., Mol Hum Reprod. 2001 May;7(5):431-6.
73. Kiba T, etal., J Gastroenterol. 2000;35(1):34-8.
74. Kim DJ, etal., Exp Mol Med. 2006 Aug 31;38(4):401-7.
75. Kim KW, etal., Spine (Phila Pa 1976). 2007 Oct 15;32(22):2443-8.
76. Kimura K and Yamamoto M, Cell Biochem Funct. 1997 Jun;15(2):81-6.
77. Kimura K, etal., Biochem Biophys Res Commun 1994 Jan 28;198(2):666-74.
78. Kitagawa M, etal., Leukemia. 1998 Apr;12(4):486-92.
79. Kotani T, etal., Leuk Res. 1994 Apr;18(4):305-10.
80. Kragh CL, etal., PLoS One. 2013;8(1):e55243. doi: 10.1371/journal.pone.0055243. Epub 2013 Jan 25.
81. Kuhla A, etal., Apoptosis. 2015 Apr;20(4):500-11. doi: 10.1007/s10495-015-1088-2.
82. Kumar V, etal., Genes Immun. 2008 Dec;9(8):689-96. doi: 10.1038/gene.2008.63. Epub 2008 Aug 7.
83. Lalor D, etal., Cell Immunol 2004 Jul;230(1):10-6.
84. Laskowska M, etal., Eur J Obstet Gynecol Reprod Biol. 2006 Jun 1;126(2):155-9. Epub 2005 Sep 19.
85. Lee J, etal., Endocrinology. 1997 May;138(5):2081-8.
86. Lee J, etal., Endocrinology. 1999 Feb;140(2):852-8.
87. Lee S, etal., Bone Marrow Transplant. 1997 Nov;20(10):883-8.
88. Lee SH, etal., Hum Pathol. 2001 Mar;32(3):250-6. doi: 10.1053/hupa.2001.22769.
89. Lee SH, etal., J Pathol. 1999 Jun;188(2):207-12. doi: 10.1002/(SICI)1096-9896(199906)188:2<207::AID-PATH337>3.0.CO;2-8.
90. Lee YH, etal., Mol Biol Rep. 2012 Dec;39(12):10671-9. doi: 10.1007/s11033-012-1957-5. Epub 2012 Oct 5.
91. Li C, etal., Pharmacogenet Genomics. 2006 Apr;16(4):245-51.
92. Li C, etal., Pharmacogenet Genomics. 2006 Apr;16(4):253-63.
93. Li H, etal., Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G263-75. Epub 2007 Nov 8.
94. Li J, etal., Diabetol Metab Syndr. 2017 Dec 1;9:94. doi: 10.1186/s13098-017-0289-y. eCollection 2017.
95. Li X, etal., Langenbecks Arch Surg. 2007 May;392(3):345-51. Epub 2007 Jan 19.
96. Li Y, etal., Front Mol Neurosci. 2018 Jun 19;11:210. doi: 10.3389/fnmol.2018.00210. eCollection 2018.
97. Li ZG, etal., Brain Res. 2005 Mar 10;1037(1-2):12-24.
98. Liang J, etal., Chem Biol Interact. 2018 Mar 1;283:30-37. doi: 10.1016/j.cbi.2018.01.014. Epub 2018 Jan 12.
99. Lima L, etal., Prostate Cancer Prostatic Dis. 2008;11(1):94-8. Epub 2007 Jul 31.
100. Liu D, etal., Zhongguo Zhong Yao Za Zhi. 2011 Dec;36(24):3484-8.
101. Liu L, etal., J Neurochem. 2008 Jul;106(2):541-50. Epub 2008 Apr 12.
102. Liu QJ, etal., Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Jul;36(4):477-9.
103. Liu Y, etal., Exp Ther Med. 2017 Dec;14(6):5345-5354. doi: 10.3892/etm.2017.5241. Epub 2017 Oct 2.
104. Lizama C, etal., Apoptosis. 2007 Mar;12(3):499-512. Epub 2006 Dec 29.
105. Lorz C, etal., J Am Soc Nephrol. 2008 May;19(5):904-14. Epub 2008 Feb 20.
106. Lu WC, etal., Int Immunopharmacol. 2018 Mar;56:1-8. doi: 10.1016/j.intimp.2018.01.005. Epub 2018 Jan 9.
107. Lucas M, etal., Eur Neurol. 2004;52(1):12-7. Epub 2004 Jun 22.
108. Luo L and Yano N, Endocr Res. 2005;31(3):185-98.
109. Ma X, etal., Mol Biol Rep. 2010 Oct;37(7):3051-6. doi: 10.1007/s11033-009-9876-9. Epub 2009 Oct 13.
110. Ma YX, etal., Zhonghua Yi Xue Za Zhi. 2007 Mar 20;87(11):734-9.
111. Maciejewski JP, etal., Br J Haematol. 1995 Sep;91(1):245-52.
112. Maedler K, etal., Diabetes. 2006 Sep;55(9):2455-62.
113. Mai W, etal., Clin Invest Med. 2012 Oct 6;35(5):E294.
114. Martin DA, etal., Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4552-7.
115. Maruoka H, etal., Thyroid. 2004 Jun;14(6):417-23.
116. Maruyama R, etal., Br J Cancer. 2006 Nov 6;95(9):1244-9. Epub 2006 Oct 10.
117. McDonnell TJ, etal., BMC Med Genomics. 2008 Jan 31;1:1.
118. MGD data from the GO Consortium
119. Mizutani Y, etal., Cancer Biother Radiopharm. 2002 Oct;17(5):563-7.
120. Molica S, etal., Haematologica. 1996 Jul-Aug;81(4):302-9.
121. Müschen M, etal., Gastroenterology. 1999 Mar;116(3):666-77. doi: 10.1016/s0016-5085(99)70189-7.
122. Nakajima H, etal., Apoptosis. 2008 Aug;13(8):1013-21. doi: 10.1007/s10495-008-0234-5.
123. Nakamura S, etal., Br J Ophthalmol. 1996 Feb;80(2):174-6.
124. NCBI rat LocusLink and RefSeq merged data July 26, 2002
125. Nishimura-Morita Y, etal., Int Immunol. 1997 Dec;9(12):1793-9.
126. Niu YL, etal., Arch Biochem Biophys. 2011 Nov;515(1-2):89-98. doi: 10.1016/j.abb.2011.07.016. Epub 2011 Aug 6.
127. Nonomura N, etal., Urology. 2000 Jan;55(1):151-5.
128. Nozawa K, etal., Arthritis Rheum. 1997 Jun;40(6):1126-9.
129. Odani-Kawabata N, etal., BMC Musculoskelet Disord. 2010 Sep 27;11:221. doi: 10.1186/1471-2474-11-221.
130. Okamura N, etal., Med Electron Microsc. 2002 Dec;35(4):234-41.
131. OMIM Disease Annotation Pipeline
132. Oria de Suarez C, etal., An Med Interna. 2006 Apr;23(4):156-60.
133. Pan HP and Li G, Yakugaku Zasshi. 2008 Nov;128(11):1689-98.
134. Pan J, etal., Neurosci Lett. 2007 Nov 27;428(2-3):82-7. Epub 2007 Sep 25.
135. Peng Y, etal., J Gastrointest Surg. 2007 Dec;11(12):1712-21. Epub 2007 Sep 25.
136. Peng Y, etal., J Surg Res. 2006 Jan;130(1):58-65. Epub 2005 Sep 8.
137. Pharmakakis NM, etal., Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):667-74. doi: 10.1007/s00417-008-0996-z. Epub 2008 Nov 28.
138. Pipeline to import KEGG annotations from KEGG into RGD
139. Pipeline to import Pathway Interaction Database annotations from NCI into RGD
140. Raguema N, etal., BJOG. 2018 Dec;125(13):1758-1764. doi: 10.1111/1471-0528.15412. Epub 2018 Sep 3.
141. Reinehr R, etal., J Biol Chem. 2008 Jan 25;283(4):2211-22. Epub 2007 Nov 28.
142. Ren C, etal., Zhonghua Xue Ye Xue Za Zhi. 2000 Apr;21(4):198-200.
143. RGD automated data pipeline
144. RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
145. RGD automated import pipeline for gene-chemical interactions
146. Rieux-Laucat F, etal., Science. 1995 Jun 2;268(5215):1347-9.
147. Rodríguez V, etal., Biomed Pharmacother. 2018 Sep;105:95-102. doi: 10.1016/j.biopha.2018.05.120. Epub 2018 May 28.
148. Rollwagen FM, etal., Biochem Biophys Res Commun. 2006 Sep 8;347(4):1094-8. Epub 2006 Jul 13.
149. Rosenbaum DM, etal., J Neurosci Res. 2000 Sep 15;61(6):686-92.
150. Roughton SA, etal., Biol Reprod. 1999 Apr;60(4):797-804.
151. Ryo K, etal., Am J Gastroenterol. 2000 Aug;95(8):2047-55. doi: 10.1111/j.1572-0241.2000.02268.x.
152. Saile B, etal., Am J Physiol Gastrointest Liver Physiol 2002 Aug;283(2):G435-44.
153. Sako T, etal., In Vivo. 2005 Jan-Feb;19(1):125-32.
154. Sato T, etal., Int J Hematol. 2000 Oct;72(3):329-36.
155. Schumann H, etal., Biochem Biophys Res Commun. 1997 Oct 29;239(3):794-8.
156. Seitz DH, etal., Shock. 2011 Jun;35(6):610-7. doi: 10.1097/SHK.0b013e318213665d.
157. Sera N, etal., Clin Exp Immunol. 2001 May;124(2):197-207.
158. Serizawa Y, etal., Histol Histopathol. 2001 Apr;16(2):453-62.
159. Shanmugam MP, etal., Ocul Immunol Inflamm. 2003 Jun;11(2):107-13.
160. Shen L, etal., Am J Pathol. 2002 Dec;161(6):2123-31.
161. Shen W, etal., Exp Cell Res. 2018 Jan 15;362(2):370-377. doi: 10.1016/j.yexcr.2017.11.038. Epub 2017 Dec 5.
162. Shi YQ, etal., Environ Toxicol. 2013 Jan;28(1):31-41. doi: 10.1002/tox.20694. Epub 2011 Mar 7.
163. Shimonishi T, etal., Hepatology. 2000 Oct;32(4 Pt 1):761-9. doi: 10.1053/jhep.2000.18192.
164. Sibley K, etal., Cancer Res. 2003 Aug 1;63(15):4327-30.
165. Slot KA, etal., J Endocrinol. 2006 Feb;188(2):179-92.
166. Song L, etal., Biomed Res Int. 2018 Jan 11;2018:8945850. doi: 10.1155/2018/8945850. eCollection 2018.
167. Strasser A, etal., Immunity. 2009 Feb 20;30(2):180-92.
168. Stricker K, etal., Cell Death Differ. 1998 Mar;5(3):222-30.
169. Stuart PM, etal., Invest Ophthalmol Vis Sci. 2003 Jan;44(1):93-8.
170. Su JH, etal., Neurobiol Dis. 2003 Apr;12(3):182-93.
171. Svatek RS, etal., Cancer. 2006 Apr 15;106(8):1701-7.
172. Sziller I, etal., Mol Hum Reprod. 2005 Mar;11(3):207-10. Epub 2005 Feb 4.
173. Takayama H, etal., Jpn J Cancer Res. 2002 Nov;93(11):1201-6.
174. Tan Z, etal., Neuroreport. 2001 Jul 3;12(9):1979-82.
175. Tsai NM, etal., J Neurochem. 2006 Nov;99(4):1251-62. Epub 2006 Sep 20.
176. Tseng-Rogenski SS, etal., Cancer Immunol Immunother. 2008 Feb 12;.
177. Utaipan T, etal., Shock. 2017 Aug;48(2):251-259. doi: 10.1097/SHK.0000000000000831.
178. van Veen T, etal., J Neuroimmunol. 2002 Jul;128(1-2):95-100.
179. Verzola D, etal., Kidney Int. 2007 Nov;72(10):1262-72. Epub 2007 Sep 12.
180. Viera NT, etal., Invest Clin. 2005 Sep;46(3):273-87.
181. Villagarcía HG, etal., Life Sci. 2018 Apr 15;199:88-95. doi: 10.1016/j.lfs.2018.03.008. Epub 2018 Mar 6.
182. Vouyouka AG, etal., Am J Surg. 2005 Nov;190(5):780-6.
183. Waetzig V, etal., Biochem Pharmacol. 2008 Dec 1;76(11):1476-84. Epub 2008 Jul 19.
184. Wahlsten JL, etal., J Immunol. 2000 Nov 15;165(10):5480-6.
185. Wang H, etal., Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Mar;15(1):12-5.
186. Wang SJ, etal., J Rheumatol. 2006 Mar;33(3):615-9.
187. Wang XD, etal., J Dent Res. 2013 Oct;92(10):918-24. doi: 10.1177/0022034513501323. Epub 2013 Aug 9.
188. Wang YJ, etal., Spine (Phila Pa 1976). 2006 Apr 1;31(7):736-41.
189. Wang YR, etal., Toxicon. 2007 Dec 15;50(8):1085-94. Epub 2007 Aug 7.
190. Wei Y, etal., Toxicol Mech Methods. 2018 Sep;28(7):507-519. doi: 10.1080/15376516.2018.1459994. Epub 2018 Jun 5.
191. Wen T, etal., Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Jul;18(7):417-20.
192. Wigginton JM, etal., J Clin Invest. 2001 Jul;108(1):51-62.
193. Wollert KC, etal., Circulation. 2000 Mar 14;101(10):1172-8.
194. Wu YQ, etal., Life Sci. 2006 May 1;78(23):2689-96. Epub 2005 Dec 9.
195. Xia M, etal., J Gastroenterol. 2002;37(12):1042-7.
196. Xu B, etal., Biosci Rep. 2018 Jun 12;38(3). pii: BSR20171529. doi: 10.1042/BSR20171529. Print 2018 Jun 29.
197. Xu J, etal., Wei Sheng Yan Jiu. 2007 Jul;36(4):443-5.
198. Xu R, etal., Wei Sheng Yan Jiu. 2010 May;39(3):358-60.
199. Xu W, etal., Toxicol Appl Pharmacol. 2017 Jan 15;315:23-34. doi: 10.1016/j.taap.2016.12.001. Epub 2016 Dec 6.
200. Yamamoto T, etal., Arch Dermatol Res. 2007 Feb;298(9):465-8. Epub 2006 Nov 11.
201. Yamana K, etal., Br J Cancer. 2005 Sep 5;93(5):544-51.
202. Yan X, etal., J Ethnopharmacol. 2018 May 8;227:105-112. doi: 10.1016/j.jep.2018.05.006.
203. Yan Y, etal., Chin Med. 2018 Apr 18;13:21. doi: 10.1186/s13020-018-0180-2. eCollection 2018.
204. Yang D, etal., Int J Cancer. 2008 Jan 15;122(2):350-62.
205. Yang L, etal., Int J Mol Sci. 2018 May 29;19(6). pii: ijms19061599. doi: 10.3390/ijms19061599.
206. Yaniv G, etal., Cardiovasc Res. 2002 Jun;54(3):611-23.
207. Yoo KC, etal., Int J Nanomedicine. 2012;7:1203-14. doi: 10.2147/IJN.S28647. Epub 2012 Mar 5.
208. Yoshimura C, etal., Eur J Haematol. 2000 Apr;64(4):219-24.
209. Younes M, etal., Hum Pathol. 2000 Apr;31(4):434-8.
210. Yu WR, etal., Brain. 2011 May;134(Pt 5):1277-92. doi: 10.1093/brain/awr054. Epub 2011 Apr 13.
211. Yue Z, etal., Environ Toxicol. 2012 Nov;27(11):653-61. doi: 10.1002/tox.20688. Epub 2011 Mar 3.
212. Zacks DN, etal., Arch Ophthalmol. 2007 Oct;125(10):1389-95.
213. Zacks DN, etal., Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4563-9.
214. Zalewska R, etal., Med Sci Monit. 2008 Dec;14(12):BR274-8.
215. Zhang B, etal., Carcinogenesis. 2007 May;28(5):1067-73. Epub 2006 Dec 20.
216. Zhang D, etal., World J Gastroenterol. 2018 Aug 14;24(30):3384-3397. doi: 10.3748/wjg.v24.i30.3384.
217. Zhang L, etal., Med Chem. 2006 Nov;2(6):611-6.
218. Zhang LJ, etal., World J Gastroenterol. 2006 Mar 28;12(12):1918-23.
219. Zhang X, etal., Parasitol Res. 2008 Jul;103(2):393-9. Epub 2008 Apr 22.
220. Zhi EL, etal., Zhonghua Nan Ke Xue. 2013 Feb;19(2):111-5.
221. Zhou M, etal., Int J Mol Med. 2010 Jun;25(6):929-35.
222. Zwolak A, etal., Hum Exp Toxicol. 2016 Aug;35(8):799-807. doi: 10.1177/0960327115607078. Epub 2015 Oct 1.
Additional References at PubMed
PMID:6610701   PMID:7511063   PMID:7536190   PMID:7538908   PMID:7595210   PMID:7602121   PMID:8524870   PMID:8557033   PMID:8640868   PMID:8666928   PMID:8700551   PMID:8788039  
PMID:9681877   PMID:9697835   PMID:10429671   PMID:10588860   PMID:10950869   PMID:11096076   PMID:11101870   PMID:12011074   PMID:12431371   PMID:12683940   PMID:12702495   PMID:12801066  
PMID:13679421   PMID:14679192   PMID:14699504   PMID:15039234   PMID:15039424   PMID:15254243   PMID:15309723   PMID:15487762   PMID:15632112   PMID:16000635   PMID:16365167   PMID:16493007  
PMID:16507998   PMID:17441510   PMID:17980593   PMID:18199416   PMID:18204739   PMID:18246871   PMID:18289516   PMID:18363966   PMID:18407603   PMID:18614532   PMID:19151726   PMID:19239001  
PMID:19267062   PMID:19399403   PMID:19407976   PMID:19415683   PMID:19593445   PMID:19642903   PMID:20436477   PMID:20448356   PMID:20458337   PMID:20530871   PMID:20935634   PMID:21052097  
PMID:21382479   PMID:21421874   PMID:21586345   PMID:21625644   PMID:21803845   PMID:21868309   PMID:22609371   PMID:22891283   PMID:23583643   PMID:23785138   PMID:23934924   PMID:23973665  
PMID:24307234   PMID:24324791   PMID:24914971   PMID:24938610   PMID:25294749   PMID:25310648   PMID:25439027   PMID:26316710   PMID:27189477   PMID:27561622   PMID:27606894   PMID:27919821  
PMID:28346613   PMID:28595623   PMID:28722192   PMID:29891925   PMID:31155748   PMID:33847039   PMID:33994507  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.21231,798,963 - 231,832,591 (+)NCBImRatBN7.2
mRatBN7.2 Ensembl1231,798,960 - 231,832,591 (+)Ensembl
Rnor_6.01252,589,785 - 252,624,790 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1252,589,785 - 252,624,790 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01259,812,248 - 259,846,107 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41238,259,443 - 238,274,745 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11238,423,465 - 238,438,767 (+)NCBI
Celera1228,912,823 - 228,946,152 (+)NCBICelera
Cytogenetic Map1q52NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38.p13 Ensembl1088,953,813 - 89,029,605 (+)EnsemblGRCh38hg38GRCh38
GRCh381088,968,429 - 89,017,059 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh371090,750,555 - 90,776,816 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361090,740,268 - 90,765,522 (+)NCBINCBI36hg18NCBI36
Build 341090,740,267 - 90,765,521NCBI
Celera1084,497,075 - 84,522,333 (+)NCBI
Cytogenetic Map10q23.31NCBI
HuRef1084,384,755 - 84,410,009 (+)NCBIHuRef
CHM1_11091,032,348 - 91,057,602 (+)NCBICHM1_1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm391934,267,926 - 34,305,175 (+)NCBIGRCm39mm39
GRCm39 Ensembl1934,268,066 - 34,305,172 (+)Ensembl
GRCm381934,290,647 - 34,327,775 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1934,290,666 - 34,327,772 (+)EnsemblGRCm38mm10GRCm38
MGSCv371934,365,149 - 34,402,260 (+)NCBIGRCm37mm9NCBIm37
MGSCv361934,356,663 - 34,393,767 (+)NCBImm8
Celera1935,067,780 - 35,104,920 (+)NCBICelera
Cytogenetic Map19C1NCBI
cM Map1929.48NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_0049554253,961,013 - 3,987,455 (-)EnsemblChiLan1.0
ChiLan1.0NW_0049554253,961,671 - 3,987,513 (-)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
PanPan1.11089,199,070 - 89,244,884 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1089,217,949 - 89,243,612 (+)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v01085,707,457 - 85,741,539 (+)NCBIMhudiblu_PPA_v0panPan3
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.12638,738,811 - 38,763,298 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2638,737,611 - 38,763,321 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha2638,489,983 - 38,514,797 (+)NCBI
ROS_Cfam_1.02640,322,559 - 40,347,441 (+)NCBI
ROS_Cfam_1.0 Ensembl2640,322,604 - 40,347,428 (+)Ensembl
UMICH_Zoey_3.12638,193,452 - 38,217,927 (+)NCBI
UNSW_CanFamBas_1.02637,756,887 - 37,781,708 (+)NCBI
UU_Cfam_GSD_1.02639,027,502 - 39,052,301 (+)NCBI
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_02440721378,564,885 - 78,583,646 (+)NCBI
SpeTri2.0NW_004936735209,369 - 234,582 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.114100,927,305 - 100,954,781 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.214109,911,730 - 109,939,489 (+)NCBISscrofa10.2Sscrofa10.2susScr3
(Heterocephalus glaber - naked mole-rat)
Naked Mole-rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla 1.0NW_00462479115,290,022 - 15,315,848 (+)NCBIHetGla_female_1.0hetGla2

Position Markers
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21231,831,132 - 231,831,370 (+)MAPPERmRatBN7.2
Rnor_6.01252,623,332 - 252,623,569NCBIRnor6.0
Rnor_5.01259,844,649 - 259,844,886UniSTSRnor5.0
RGSC_v3.41238,273,287 - 238,273,524UniSTSRGSC3.4
Celera1228,944,694 - 228,944,931UniSTS
Cytogenetic Map1q52UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21231,832,364 - 231,832,521 (+)MAPPERmRatBN7.2
Rnor_6.01252,624,564 - 252,624,720NCBIRnor6.0
Rnor_5.01259,845,881 - 259,846,037UniSTSRnor5.0
RGSC_v3.41238,274,519 - 238,274,675UniSTSRGSC3.4
Celera1228,945,926 - 228,946,082UniSTS
RH 3.4 Map4490.22UniSTS
Cytogenetic Map1q52UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21231,832,140 - 231,832,304 (+)MAPPERmRatBN7.2
Rnor_6.01252,624,340 - 252,624,503NCBIRnor6.0
Rnor_5.01259,845,657 - 259,845,820UniSTSRnor5.0
RGSC_v3.41238,274,295 - 238,274,458UniSTSRGSC3.4
Celera1228,945,702 - 228,945,865UniSTS
Cytogenetic Map1q52UniSTS

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2292216Bw80Body weight QTL 803.230.0019body mass (VT:0001259)body weight (CMO:0000012)1213533809243914901Rat
70211Niddm24Non-insulin dependent diabetes mellitus QTL 243.79blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1214647894259647894Rat
631215Stl8Serum triglyceride level QTL 89.270.0001blood triglyceride amount (VT:0002644)serum triglyceride level (CMO:0000360)1225126575260522016Rat
2302040Pia35Pristane induced arthritis QTL 353.80.001blood immunoglobulin amount (VT:0002460)serum immunoglobulin G1 level (CMO:0002115)1216255568260522016Rat
2302375Bw83Body weight QTL 834.870.0002body mass (VT:0001259)body weight (CMO:0000012)1197697768242697768Rat
2302378Insul11Insulin level QTL 113.25blood insulin amount (VT:0001560)serum insulin level (CMO:0000358)1144267353251128347Rat
61455Niddm7Non-insulin dependent diabetes mellitus QTL 75.5blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)1214537555238757011Rat
724531Uae5Urinary albumin excretion QTL 54urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)1150700142252085212Rat
724533Rf51Renal function QTL 515.30.0002kidney plasma flow trait (VT:0005524)renal plasma flow (CMO:0001914)1218753816256448513Rat
724538Kidm1Kidney mass QTL 13.2kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1213707201252085212Rat
724552Glom2Glomerulus QTL 23.30.0001kidney glomerulus morphology trait (VT:0005325)count of superficial glomeruli directly contacting the kidney surface (CMO:0001001)1222363780260522016Rat
734767Niddm57Non-insulin dependent diabetes mellitus QTL 57body mass (VT:0001259)body weight (CMO:0000012)1224054293260122809Rat
734768Niddm59Non-insulin dependent diabetes mellitus QTL 59body mass (VT:0001259)body weight (CMO:0000012)1213843987258843987Rat
734769Niddm58Non-insulin dependent diabetes mellitus QTL 58body mass (VT:0001259)body weight (CMO:0000012)1224569538260122809Rat
1298084Thym4Thymus enlargement QTL 410.68thymus mass (VT:0004954)thymus weight to body weight ratio (CMO:0000612)1197814409242814409Rat
631658Cm7Cardiac mass QTL 75.320.0001aorta mass (VT:0002845)aorta weight (CMO:0000076)1196248093241248093Rat
1354580Scort1Serum corticosterone level QTL 13.4blood corticosterone amount (VT:0005345)blood corticosterone level (CMO:0001172)1156677124256448636Rat
731175Uae20Urinary albumin excretion QTL 203.50.0018urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1221264111259647894Rat
738032Hcas5Hepatocarcinoma susceptibility QTL 53.12liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1176426412257976495Rat
1641926Teswt2Testicular weight QTL 22.82testis mass (VT:1000644)both testes wet weight (CMO:0000175)1197697768238755659Rat
1598821Rf55Renal function QTL 556.3renal blood flow trait (VT:2000006)ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239)1218748008257976495Rat
2300175Bmd40Bone mineral density QTL 4015.40.0001femur mineral mass (VT:0010011)bone mineral density (CMO:0001226)1201554356246554356Rat
2293655Bss36Bone structure and strength QTL 3610.660.0001femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)1201554356246554356Rat
2293674Bss39Bone structure and strength QTL 397.10.0001femur strength trait (VT:0010010)femur total energy absorbed before break (CMO:0001677)1201554356246554356Rat
2293694Bss38Bone structure and strength QTL 387.050.0001femur strength trait (VT:0010010)femur stiffness (CMO:0001674)1201554356246554356Rat
2293700Bmd27Bone mineral density QTL 276.60.0001femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)1224054293243747962Rat
2293701Bmd34Bone mineral density QTL 348.30.0001femur strength trait (VT:0010010)femoral neck ultimate force (CMO:0001703)1224054293243747962Rat
631843Bw116Body weight QTL 1164.10.016abdominal adipose amount (VT:1000220)abdominal fat pad weight (CMO:0000088)1224054293260122809Rat
634313Niddm43Non-insulin dependent diabetes mellitus QTL 43blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1199050459259647894Rat
634321Hc1Hypercalciuria QTL 12.91urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1178810256240830002Rat
1357335Bw39Body weight QTL 393.3body mass (VT:0001259)body weight (CMO:0000012)1197814409242814409Rat
1357399Bw45Body weight QTL 453.05body mass (VT:0001259)body mass index (BMI) (CMO:0000105)1206329708251329708Rat
1357404Bw42Body weight QTL 424.490.0001body mass (VT:0001259)body weight (CMO:0000012)1206329708251329708Rat
1600363Hc6Hypercalciuria QTL 62.7urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1203995416244113296Rat
1600374Mcs17Mammary carcinoma susceptibility QTL 173mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)1197670404242670404Rat
1600388Niddm67Non-insulin dependent diabetes mellitus QTL 675.840.000004blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1195804352257091168Rat
1600392Bw123Body weight QTL 1230.001body mass (VT:0001259)body weight (CMO:0000012)1223201027260522016Rat
1600395Niddm69Non-insulin dependent diabetes mellitus QTL 694.140.0002blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)1195804352257091168Rat
1600396Niddm68Non-insulin dependent diabetes mellitus QTL 684.970.0003blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1195804352257091168Rat
1600397Edcs4Endometrial carcinoma susceptibility QTL 42.2uterus morphology trait (VT:0001120)percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759)1206081677251081677Rat
1578759Uae30Urinary albumin excretion QTL 303.30.003urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1150700247252085048Rat
1578763Kidm29Kidney mass QTL 293.30.0001kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)1179567751260522016Rat
1578778Pur4Proteinuria QTL 43.30.003total urine protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)1150700247252085048Rat
1300108Rf8Renal function QTL 83.75renal blood flow trait (VT:2000006)absolute change in renal vascular resistance (CMO:0001900)1228581588259647894Rat
1354610Bw34Body weight QTL 344.1body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1354624Cm35Cardiac mass QTL355.7heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1177227632256448636Rat
1354646Kidm18Kidney mass QTL 185.7kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512256448636Rat
1354652Kidm20Kidney mass QTL 204.3kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1177227632256448636Rat
1354661Bw33Body weight QTL 335.2body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1549910Bw54Body weight QTL 540.05body mass (VT:0001259)body weight (CMO:0000012)1214647894259647894Rat
2316896Gluco57Glucose level QTL 577.2blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1228985440245907899Rat
1549837Hcar15Hepatocarcinoma resistance QTL 150.05liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1153136852260522016Rat
1358191Ept10Estrogen-induced pituitary tumorigenesis QTL 103.8pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)1192825253243914732Rat
2292220Bp306Blood pressure QTL 3063.470.00087arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393243914901Rat
1358890Bp259Blood pressure QTL 2593.06arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1210702053260522016Rat
1358898Bp255Blood pressure QTL 2553.6arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1191019702246062233Rat
1358916Kidm22Kidney mass QTL 223.32kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1210702053240947965Rat
1358292Cm37Cardiac mass QTL 376.20.00000081heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)1196248093241248093Rat
61327Eae7Experimental allergic encephalomyelitis QTL 75.6body mass (VT:0001259)change in body weight (CMO:0002045)1216255568260522016Rat
61376Bp42Blood pressure QTL 4223.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1197814409242814409Rat
61400Niddm1Non-insulin dependent diabetes mellitus QTL 111blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1218753689245907899Rat
8655655Arrd2Age-related retinal degeneration QTL 27.79retinal layer morphology trait (VT:0003727)percentage of study population developing retinopathy during a period of time (CMO:0002453)1183970203243914901Rat
7794788Mcs32Mammary carcinoma susceptibility QTL 322.61mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)1115540693238914717Rat
7421630Bp362Blood pressure QTL 3620.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118608292241799120Rat
8552891Epfw5Epididymal fat weight QTL 54.4epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)1193113876238113876Rat
7394701Uae46Urinary albumin excretion QTL 463.60.0056urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1201554356246554356Rat
8655855Arrd3Age-related retinal degeneration QTL 33.07lens clarity trait (VT:0001304)cataract incidence/prevalence measurement (CMO:0001585)1183970203243914901Rat
10053715Scort24Serum corticosterone level QTL 242.130.0088blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)1221414816260522016Rat
10059587Bw173Body weight QTL 1733.230.025body mass (VT:0001259)body weight (CMO:0000012)1202069611247069611Rat
10059590Kidm44Kidney mass QTL 443.420.025kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1191033875236033875Rat

miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:99
Count of miRNA genes:85
Interacting mature miRNAs:96
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 1 10 2 14 2 1 11
Low 2 43 47 39 5 39 8 11 69 35 35 8
Below cutoff 5 5


Reference Sequences
RefSeq Acc Id: ENSRNOT00000025928   ⟹   ENSRNOP00000025928
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1231,798,971 - 231,832,591 (+)Ensembl
Rnor_6.0 Ensembl1252,589,785 - 252,624,790 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000094083   ⟹   ENSRNOP00000079622
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1231,798,960 - 231,819,290 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000112109   ⟹   ENSRNOP00000096262
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1231,798,990 - 231,832,227 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000114760   ⟹   ENSRNOP00000089144
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1231,817,043 - 231,831,067 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000119978   ⟹   ENSRNOP00000082757
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1231,798,971 - 231,832,591 (+)Ensembl
RefSeq Acc Id: NM_139194   ⟹   NP_631933
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
mRatBN7.21231,798,963 - 231,832,591 (+)NCBI
Rnor_6.01252,589,785 - 252,624,790 (+)NCBI
Rnor_5.01259,812,248 - 259,846,107 (+)NCBI
RGSC_v3.41238,259,443 - 238,274,745 (+)RGD
Celera1228,912,823 - 228,946,152 (+)RGD
Protein Sequences
Protein RefSeqs NP_631933 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAD20221 (Get FASTA)   NCBI Sequence Viewer  
  BAA05109 (Get FASTA)   NCBI Sequence Viewer  
  EDM13158 (Get FASTA)   NCBI Sequence Viewer  
  EDM13159 (Get FASTA)   NCBI Sequence Viewer  
  Q63199 (Get FASTA)   NCBI Sequence Viewer  
Reference Sequences
RefSeq Acc Id: NP_631933   ⟸   NM_139194
- Peptide Label: precursor
- UniProtKB: Q63199 (UniProtKB/Swiss-Prot),   F1LWQ2 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000025928   ⟸   ENSRNOT00000025928
RefSeq Acc Id: ENSRNOP00000079622   ⟸   ENSRNOT00000094083
RefSeq Acc Id: ENSRNOP00000082757   ⟸   ENSRNOT00000119978
RefSeq Acc Id: ENSRNOP00000089144   ⟸   ENSRNOT00000114760
RefSeq Acc Id: ENSRNOP00000096262   ⟸   ENSRNOT00000112109
Protein Domains
Death   TNFR-Cys


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13690863
Promoter ID:EPDNEW_R1387
Type:multiple initiation site
Description:Fas cell surface death receptor
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.01252,589,835 - 252,589,895EPDNEW

Strain Variation

Strain Sequence Variants (Rnor 6.0)
ACI/EurMcwi (2019)
Visual CSV TAB Printer
Sequenced By: MCW
Platform: GSPMC-Illumina-NovaSeq6000
Secondary Analysis: BWA_mem_v.0.7.17,_GATK_v.
Breeder: MCW
Description: Dr. Mindy Dwinell - Hybrid rat diversity program
ACI/EurMcwi (MCW)
Visual CSV TAB Printer
Sequenced By: Medical College of Wisconsin (Dr. Howard Jacob)
Platform: Illumina HiSeq 2000
Secondary Analysis: BWA v0.7.7 and GATK v3.2-2
Breeder: Medical College of Wisconsin
Description: Provided by the Medical College of Wisconsin (Dr. Howard Jacob)
ACI/EurMcwi (RGD)
Visual CSV TAB